Eris Lifesciences Limited ERIS.BO
ERIS.BO
Eris Lifesciences Limited NEULANDLAB.NS
Neuland Laboratories Limited NEULANDLAB.BO
Neuland Laboratories Limited ASTRAZEN.NS
AstraZeneca Pharma India Limited ASTRAZEN.BO
AstraZeneca Pharma India Limited WOCKPHARMA.NS
Wockhardt Limited WOCKPHARMA.BO
Wockhardt Limited APLLTD.NS
Alembic Pharmaceuticals Limited PEL.NS
Piramal Enterprises Limited APLLTD.BO
Alembic Pharmaceuticals Limited
Eris Lifesciences Limited NEULANDLAB.NS
Neuland Laboratories Limited NEULANDLAB.BO
Neuland Laboratories Limited ASTRAZEN.NS
AstraZeneca Pharma India Limited ASTRAZEN.BO
AstraZeneca Pharma India Limited WOCKPHARMA.NS
Wockhardt Limited WOCKPHARMA.BO
Wockhardt Limited APLLTD.NS
Alembic Pharmaceuticals Limited PEL.NS
Piramal Enterprises Limited APLLTD.BO
Alembic Pharmaceuticals Limited
Performance
| Periode | ERIS.BO | NEULANDLAB.NS | NEULANDLAB.BO | ASTRAZEN.NS | ASTRAZEN.BO | WOCKPHARMA.NS | WOCKPHARMA.BO | APLLTD.NS | PEL.NS | APLLTD.BO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 13.42 % | 24.44 % | 24.08 % | 3.73 % | 4.01 % | -2.72 % | -2.85 % | 9.00 % | 9.10 % | 8.93 % |
| YTD | 19.10 % | 13.80 % | 13.43 % | 29.33 % | 29.07 % | -5.70 % | -5.92 % | -11.08 % | 2.70 % | -11.09 % |
| 1Y | 24.27 % | 21.82 % | 21.67 % | 29.43 % | 29.49 % | 34.62 % | 34.37 % | -14.45 % | 9.61 % | -14.55 % |
| 3Y | 115.10 % | 984.72 % | 983.00 % | 201.02 % | 201.61 % | 471.84 % | 301.45 % | 70.08 % | 33.43 % | 69.88 % |
| 5Y | 210.94 % | 1 264.45 % | 1 264.17 % | 120.04 % | 121.19 % | 367.70 % | 301.45 % | -7.84 % | 55.43 % | -7.86 % |
| 10Y | 163.84 % | 1 941.28 % | 1 939.06 % | 648.80 % | 649.58 % | -12.56 % | 301.45 % | 34.33 % | 114.64 % | 34.01 % |
| From the beginning | 163.84 % | 14 585.38 % | 10 570.53 % | 31 235.02 % | 15 936.47 % | 742.92 % | 301.45 % | 1 945.61 % | 4 306.90 % | 1 930.61 % |